Welcome to our dedicated page for Dss news (Ticker: DSS), a resource for investors and traders seeking the latest updates and insights on Dss stock.
DSS, Inc. (NYSE American: DSS) generates news across a wide range of sectors, reflecting its role as a multinational company with diversified business lines in packaging, biohealth innovation, financial services, alternative trading, and real estate. The company’s press releases and regulatory disclosures highlight strategic transactions, capital markets developments, operational milestones, and portfolio optimization efforts.
News about DSS often covers corporate strategy and portfolio management, including spin-offs, asset sales, and transactions involving key subsidiaries. Examples include the sale of the Celios air purification asset to Impact BioMedical Inc., as well as a definitive merger agreement under which Impact BioMedical will be acquired through a reverse merger with Dr. Ashleys Limited, resulting in a new public company. These items illustrate DSS’s stated approach of unlocking value by advancing subsidiaries toward independent public listings and other exit opportunities.
Investors and followers of DSS can also expect updates on financial performance and corporate actions. The company reports on revenue trends, cash flow improvements, debt reduction, and asset monetization, such as the sale of a real estate facility and growth in rental income. Leadership communications, including letters to shareholders and announcements of executive appointments, provide additional context on strategic priorities, cost reduction initiatives, and the focus on core growth verticals.
Because DSS has subsidiaries in securities and investment management, its news flow includes developments at entities like Sentinel Brokers Company, Inc. and AmericaFirst Funds. These updates may involve regulatory approvals, such as FINRA authorization for underwriting activities, changes to mutual fund boards, and expansion of capital markets capabilities. For a comprehensive view of DSS-related developments, readers can use this news page to follow corporate strategy, subsidiary activity, and key financial and regulatory events over time.
Document Security Systems (DSS) has successfully closed an upsized public offering, generating $24 million in gross proceeds. The company issued 6,666,666 shares at a price of $3.60 each, with plans to utilize the funds for developing new business lines, acquisition opportunities, and general corporate needs. Additionally, underwriters have a 45-day option to purchase up to 15% more shares, potentially raising total gross proceeds to approximately $27.6 million.
Document Security Systems, Inc. (DSS) announced an upsized public offering expected to raise approximately $24 million, selling 6,666,666 shares at $3.60 each. Proceeds will support the development of new business lines, acquisitions, and general corporate needs. There is a 45-day option for underwriters to purchase an additional 15% of shares, potentially raising total proceeds to $27.6 million. Aegis Capital Corp. is the sole bookrunner for this offering, which was registered with the SEC on January 19, 2021.
Document Security Systems (DSS) announced that its subsidiary, Impact BioMedical, has entered into an investment and distribution agreement with Nano9 Labs. This partnership aims to enhance DSS's product offerings by adding private-labeled nutraceutical lines to its existing portfolio, leveraging Nano9's advanced delivery technology for better bioavailability. DSS expects this collaboration to boost its direct marketing revenue significantly, especially in the U.S. and Asia. The nutraceutical market is projected to grow substantially, providing ample opportunity for DSS's expansion.
Document Security Systems (DSS) announced that its subsidiary, Impact BioMedical, received a notice of patent allowance for its 3F Biofragrance, a botanical-based insect repellent. The patent protects its method of use against mosquitoes, leveraging terpenes to affect insect receptors. The global insect repellent market is projected to reach $9.6 billion by 2026, indicating significant commercial potential for DSS's innovation. CEO Frank D. Heuszel highlighted the expanded intellectual property estate and the substantial long-term value for shareholders as the product moves toward commercialization.
Document Security Systems (NYSE American: DSS) announced a 10-year exclusive distribution agreement with BioMed Technology Asia Pacific Holdings Limited to market and distribute various probiotic products across key markets including the US, Canada, and South Korea. The company will also purchase shares in BioMed valued at approximately $630,000, allowing them to appoint a director on BioMed’s board. The global probiotics market, valued at $48 billion in 2018, is projected to grow at a CAGR of 6.9% through 2025, indicating potential revenue growth for DSS's subsidiary Impact BioMedical.
DSS, a multinational company, announces its rebranding to Alset, Inc., with a proposed ticker symbol change pending shareholder approval after December 8. This change reflects the company's expanded business operations beyond document security, including sectors like healthcare and real estate. Chairman Chan Heng Fai emphasizes a diversified portfolio aimed at profitability and shareholder value through mergers and acquisitions. DSS continues to experience growth in anti-counterfeiting and packaging solutions, alongside new high-margin opportunities in direct marketing and real estate.
Document Security Systems, Inc. (DSS) has promoted Todd D. Macko to interim Chief Financial Officer effective October 28, 2020. Macko, a Certified Public Accountant with over 25 years in corporate finance, will leverage his expertise in financial planning and mergers and acquisitions to advance DSS's strategic initiatives. Previously the Vice President of Finance at DSS, he has been integral in financial leadership and reporting. DSS focuses on brand protection, blockchain security, and other sectors, with plans for shareholders to benefit from future spin-offs of its subsidiaries.
Document Security Systems (DSS) reported a 59% revenue increase in Q3 2020, reaching $4.2 million. The company achieved net income of $5.4 million or $1.20 per share, a significant turnaround from a loss of $1.2 million in Q3 2019. Stockholders’ equity surged 496% to $73.3 million. Key developments include the acquisition of Impact BioMedical, a special dividend declaration, and a multi-year contract worth $3.2 million annually. DSS also launched the AuthentiGuard as a Service app and expanded its research initiatives.
DSS (NYSE American: DSS) announced the appointment of Frank D. Heuszel and Sassuan (Sam) Lee to the board of Sharing Services Global Corp (OTCQB: SHRG), where DSS holds a 37% ownership stake. Heuszel expressed enthusiasm about leveraging his experience to enhance shareholder value and grow the company's independent representative network. The collaboration aims to expand Sharing Services' market reach and product offerings, enhancing its competitive position within the direct selling industry.
Document Security Systems (DSS) has reaffirmed its plans for a two-part special share dividend of Impact BioMedical shares. Shareholders as of September 7, 2020, will receive two Bonus Shares for each DSS share held. The Bonus Shares will be distributed after Impact BioMedical's IPO, targeted for 2021. Although there are no guarantees regarding the IPO or share distribution due to market conditions, the company is committed to this path. Impact BioMedical, acquired by DSS in August 2020, holds antiviral technologies valued at $382 million.